Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -1973.80%, near the high end of its 5-year range (-17188.74%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-2832.68%
NET PROFIT MARGIN AVG 5Y
-1973.80%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Praxis Precision Medicines, Inc.
Market Cap
$7.81B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2832.68%
5Y Avg
-1973.80%
Market Cap
$7.76B
Net Profit Margin
10.62%
TTM Avg
-67.31%
3Y Avg
-92.57%
5Y Avg
-72.17%
Market Cap
$7.63B
Net Profit Margin
-1259.87%
TTM Avg
-2041.36%
3Y Avg
-2870.64%
5Y Avg
-2002.71%
Market Cap
$7.99B
Net Profit Margin
55.22%
TTM Avg
39.84%
3Y Avg
-1987.81%
5Y Avg
-32826.44%
Market Cap
$7.61B
Net Profit Margin
17.36%
TTM Avg
12.22%
3Y Avg
6.75%
5Y Avg
3.72%
Market Cap
$7.61B
Net Profit Margin
15.15%
TTM Avg
-46.46%
3Y Avg
-43.29%
5Y Avg
-43.29%
Market Cap
$7.31B
Net Profit Margin
-64.64%
TTM Avg
-52.37%
3Y Avg
-49.29%
5Y Avg
-43.60%
Market Cap
$8.38B
Net Profit Margin
3.60%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | $7.81B | 0.00% | 0.00% | -2832.68% | -1973.80% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.76B | 10.62% | -67.31% | -92.57% | -72.17% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.63B | -1259.87% | -2041.36% | -2870.64% | -2002.71% |
| TG Therapeutics, Inc. (TGTX)vs › | $7.99B | 55.22% | 39.84% | -1987.81% | -32826.44% |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 17.36% | 12.22% | 6.75% | 3.72% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 15.15% | -46.46% | -43.29% | -43.29% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.31B | -64.64% | -52.37% | -49.29% | -43.60% |
| Oscar Health, Inc. (OSCR)vs › | $8.38B | 3.60% | -1.75% | -5.71% | -20.27% |
| Alkermes plc (ALKS)vs › | $6.99B | 3.97% | 19.97% | 11.77% | 5.39% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.67B | -47.79% | -8441.28% | -4260.06% | -2873.03% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -786.27% |
| 2024-09-30 | -17188.74% |
| 2024-06-30 | -9153.22% |
| 2024-03-31 | -9177.03% |
| 2023-12-31 | -5219.03% |
| 2023-09-30 | -5263.25% |
| 2023-06-30 | -4393.34% |
| 2023-03-31 | -5483.89% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
